| Symbol | ANIX |
|---|---|
| Name | ANIXA BIOSCIENCES INC |
| Sector | UNDEFINED |
| Region | UNDEFINED |
| Industry | Pharmaceutical Preparations |
| Address | 3150 ALMADEN EXPRESSWAY, SUITE 250, SAN JOSE, CA 95118 |
| Telephone | 408-708-9808 |
| Fax | — |
| — | |
| Website | — |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | — |
| Description | None |
Anixa Biosciences Announces Presentation of its Ovarian Cancer CAR-T Therapy at the International Society for Cell & Gene Therapy 2026 Annual Meeting
Read moreAnixa Biosciences to Participate in RedChips Biotech Resurgence: Platforms and Pipelines of Todays Innovators Conference on April 16, 2026
Read moreAnixa Biosciences to Participate in Water Tower Research Insights Conference on April 14, 2026
Read moreAnixa Biosciences CEO Featured on Smart Money Circle Interview Highlighting Advances in Cancer Immunotherapy Programs
Read moreAnixa Biosciences CEO Featured on Smart Money Circle Interview Highlighting Advances in Cancer Immunotherapy Programs
Read moreAnixa Biosciences Advances Breast Cancer Vaccine Toward Phase 2 After Positive Phase 1 Results; Cytovance Selected for cGMP Manufacturing
Read moreAnixa Biosciences Announces Presentation of its Ovarian Cancer CAR-T Therapy Clinical Trial at the Society of Gynecologic Oncology Annual Meeting on Womens Cancer
Read moreAnixa Biosciences Featured on Water Tower Research Healthcare Happenings Podcast
Read moreAnixa Biosciences Featured on Water Tower Research Healthcare Happenings Podcast
Read more